Sphera Funds Management’s MediWound MDWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.4M Buy
273,192
+42,845
+19% +$745K 0.7% 52
2025
Q4
$4.25M Buy
230,347
+45,077
+24% +$824K 0.82% 48
2025
Q3
$3.34M Buy
+185,270
New +$3.42M 0.7% 47
2024
Q1
Sell
-48,980
Closed -$498K 115
2023
Q4
$498K Sell
48,980
-59,553
-55% -$535K 0.08% 90
2023
Q3
$1.15M Sell
108,533
-2,594
-2% -$23.8K 0.21% 75
2023
Q2
$1.18M Hold
111,127
0.19% 82
2023
Q1
$1.48M Buy
111,127
+35,714
+47% +$450K 0.25% 65
2022
Q4
$1.02M Sell
75,413
-22,975
-23% -$233K 0.22% 49
2022
Q3
$958K Buy
+98,388
New +$1.24M 0.13% 63

Other funds holding MDWD

Sphera Funds Management's MDWD Position: Q1 2026 in Review

Sphera Funds Management increased its MediWound (MDWD) stake by 19% in Q1 2026, buying an estimated $745K and bringing the position to 273,192 shares worth $4.4M. The position accounts for 0.7% of the portfolio, ranked #52.

Sphera Funds Management first reported a position in MDWD in Q3 2022 and has held it in 9 quarters since. 76 funds tracked by Wall St. Rank hold MDWD as of Q1 2026.

  • Sphera Funds Management held 273,192 shares of MediWound worth $4.4M as of Q1 2026.
  • Sphera Funds Management bought 42,845 MediWound shares in Q1 2026, an estimated $745K.
  • MediWound made up 0.7% of Sphera Funds Management's portfolio in Q1 2026, its #52 holding.
  • Sphera Funds Management first reported a position in MediWound in Q3 2022 and has held it in 9 quarters since.
  • 76 funds tracked by Wall St. Rank held MediWound as of Q1 2026.

Based on Sphera Funds Management's 13F filing for Q1 2026, filed 15 May 2026.